These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 9537437

  • 1. Variant liver estrogen receptor transcripts already occur at an early stage of chronic liver disease.
    Villa E, Dugani A, Moles A, Camellini L, Grottola A, Buttafoco P, Merighi A, Ferretti I, Esposito P, Miglioli L, Bagni A, Troisi R, De Hemptinne B, Praet M, Callea F, Manenti F.
    Hepatology; 1998 Apr; 27(4):983-8. PubMed ID: 9537437
    [Abstract] [Full Text] [Related]

  • 2. The clinical and pathogenetic significance of estrogen receptor-beta expression in chronic liver diseases and liver carcinoma.
    Iavarone M, Lampertico P, Seletti C, Francesca Donato M, Ronchi G, del Ninno E, Colombo M.
    Cancer; 2003 Aug 01; 98(3):529-34. PubMed ID: 12879470
    [Abstract] [Full Text] [Related]

  • 3. Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival.
    Villa E, Moles A, Ferretti I, Buttafoco P, Grottola A, Del Buono M, De Santis M, Manenti F.
    Hepatology; 2000 Aug 01; 32(2):233-8. PubMed ID: 10915729
    [Abstract] [Full Text] [Related]

  • 4. Variant estrogen receptor messenger RNA species detected in human primary hepatocellular carcinoma.
    Villa E, Camellini L, Dugani A, Zucchi F, Grottola A, Merighi A, Buttafoco P, Losi L, Manenti F.
    Cancer Res; 1995 Feb 01; 55(3):498-500. PubMed ID: 7834616
    [Abstract] [Full Text] [Related]

  • 5. Estrogen receptors, progesterone receptors and heat-shock 27-kD protein in liver biopsy specimens from patients with hepatitis B virus infection.
    Ciocca DR, Jorge AD, Jorge O, Milutín C, Hosokawa R, Díaz Lestren M, Muzzio E, Schulkin S, Schirbu R.
    Hepatology; 1991 May 01; 13(5):838-44. PubMed ID: 1851492
    [Abstract] [Full Text] [Related]

  • 6. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S, Nakashima Y, Kojiro M, Tabor E.
    J Viral Hepat; 2005 May 01; 12(3):325-9. PubMed ID: 15850475
    [Abstract] [Full Text] [Related]

  • 7. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K, Pal NS, Arora SK.
    Indian J Pathol Microbiol; 2006 Jul 01; 49(3):357-61. PubMed ID: 17001884
    [Abstract] [Full Text] [Related]

  • 8. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A, Nishiguchi S, Kubo S, Narimatsu T, Habu D, Takeda T, Hirohashi K, Shiomi S.
    J Med Virol; 2003 Dec 01; 71(4):492-8. PubMed ID: 14556260
    [Abstract] [Full Text] [Related]

  • 9. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
    Tsatsralt-Od B, Takahashi M, Nishizawa T, Endo K, Inoue J, Okamoto H.
    J Med Virol; 2005 Dec 01; 77(4):491-9. PubMed ID: 16254981
    [Abstract] [Full Text] [Related]

  • 10. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.
    Huo TI, Wu JC, Lee PC, Chau GY, Lui WY, Tsay SH, Ting LT, Chang FY, Lee SD.
    Hepatology; 1998 Jul 01; 28(1):231-6. PubMed ID: 9657117
    [Abstract] [Full Text] [Related]

  • 11. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
    El-Bassiouni A, Nosseir M, Zoheiry M, El-Ahwany E, Ghali A, El-Bassiouni N.
    APMIS; 2006 Jun 01; 114(6):420-7. PubMed ID: 16856963
    [Abstract] [Full Text] [Related]

  • 12. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
    Squadrito G, Pollicino T, Cacciola I, Caccamo G, Villari D, La Masa T, Restuccia T, Cucinotta E, Scisca C, Magazzu D, Raimondo G.
    Cancer; 2006 Mar 15; 106(6):1326-30. PubMed ID: 16453330
    [Abstract] [Full Text] [Related]

  • 13. Influence of occult hepatitis B virus coinfection on the incidence of fibrosis and hepatocellular carcinoma in chronic hepatitis C.
    Matsuoka S, Nirei K, Tamura A, Nakamura H, Matsumura H, Oshiro S, Arakawa Y, Yamagami H, Tanaka N, Moriyama M.
    Intervirology; 2008 Mar 15; 51(5):352-61. PubMed ID: 19127078
    [Abstract] [Full Text] [Related]

  • 14. Hormonal therapy with megestrol in inoperable hepatocellular carcinoma characterized by variant oestrogen receptors.
    Villa E, Ferretti I, Grottola A, Buttafoco P, Buono MG, Giannini F, Manno M, Bertani H, Dugani A, Manenti F.
    Br J Cancer; 2001 Apr 06; 84(7):881-5. PubMed ID: 11286465
    [Abstract] [Full Text] [Related]

  • 15. [Significance and expression of insulin-like growth factor II and its receptor in hepatocellular carcinogenesis].
    Fan Z, Yang D, Qin H.
    Zhonghua Gan Zang Bing Za Zhi; 2000 Apr 06; 8(2):84-6. PubMed ID: 10861110
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
    Dohmen K, Shigematsu H, Irie K, Ishibashi H.
    Hepatogastroenterology; 2003 Apr 06; 50(54):2022-7. PubMed ID: 14696457
    [Abstract] [Full Text] [Related]

  • 17. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G, Pantalena M, Zagni I, Realdi G, Schalm SW, Christensen E, European Concerted Action on Viral Hepatitis (EUROHEP).
    Am J Gastroenterol; 2002 Nov 06; 97(11):2886-95. PubMed ID: 12425564
    [Abstract] [Full Text] [Related]

  • 18. The quantification of cytochrome P-450 (CYP 3A4) mRNA in the blood of patients with viral liver diseases.
    Horiike N, Abe M, Kumagi T, Hiasa Y, Akbar SM, Michitaka K, Onji M.
    Clin Biochem; 2005 Jun 06; 38(6):531-4. PubMed ID: 15885232
    [Abstract] [Full Text] [Related]

  • 19. Receptor activator of nuclear factor-kappaB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis.
    Sasaki A, Ishikawa K, Haraguchi N, Inoue H, Ishio T, Shibata K, Ohta M, Kitano S, Mori M.
    Ann Surg Oncol; 2007 Mar 06; 14(3):1191-9. PubMed ID: 17195907
    [Abstract] [Full Text] [Related]

  • 20. [HBs Ag and antibodies to hepatitis C virus in complicated chronic liver disease in Gabon. A case control study].
    Perret JL, Moussavou-Kombila JB, Delaporte E, Pemba LF, Boguikouma JB, Matton T, Larouze B.
    Gastroenterol Clin Biol; 2002 Feb 06; 26(2):131-5. PubMed ID: 11938063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.